New weight loss pill could replace shots: early safety study begins

NCT ID NCT07388667

Recruiting now Symptom relief Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 26, 2026 · Updated 11 times

Summary

This early study tests MK-4082, a new weight loss pill, in 120 healthy overweight or obese adults. The goal is to find a safe dose and see how the body handles it. Unlike many weight loss drugs that are injections, this one is taken as a pill. The study focuses on safety and side effects, not weight loss itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anaheim Clinical Trials ( Site 0005)
RECRUITING

Anaheim, California, 92801, United States

Contact Phone: •••-•••-••••
Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0004)
ACTIVE_NOT_RECRUITING

Springfield, Missouri, 65802, United States
Hassman Research Institute Marlton Site ( Site 0006)
RECRUITING

Marlton, New Jersey, 08053, United States

Contact Phone: •••-•••-••••
ProSciento Inc. ( Site 0002)
RECRUITING

Chula Vista, California, 91911, United States

Contact Phone: •••-•••-••••
QPS-MRA, LLC ( Site 0003)
RECRUITING

South Miami, Florida, 33143, United States

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

HEALTHY